Dalpiciclib partially abrogates ER signaling activation induced by pyrotinib in HER2+HR+ breast cancer

Bu, JW; Zhang, YX; Niu, N; Bi, KW; Sun, LS; Qiao, XB; Wang, YM; Zhang, YA; Jiang, XF; Wang, D; Ma, QT; Li, HJ; Liu, CG

Liu, CG (通讯作者),China Med Univ, Innovat Canc Drug Res & Dev Engn Ctr Liaoning Prov, Dept Oncol, Canc Stem Cell & Translat Med Lab,Shengjing Hosp, Shenyang, Peoples R China.

ELIFE, 2023; 12 ():